"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
Descriptor ID |
D008175
|
MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 11 | 5 | 16 |
1996 | 10 | 4 | 14 |
1997 | 9 | 0 | 9 |
1998 | 13 | 1 | 14 |
1999 | 8 | 4 | 12 |
2000 | 12 | 1 | 13 |
2001 | 12 | 5 | 17 |
2002 | 22 | 9 | 31 |
2003 | 32 | 13 | 45 |
2004 | 30 | 8 | 38 |
2005 | 35 | 10 | 45 |
2006 | 32 | 12 | 44 |
2007 | 41 | 9 | 50 |
2008 | 43 | 9 | 52 |
2009 | 36 | 4 | 40 |
2010 | 45 | 4 | 49 |
2011 | 54 | 11 | 65 |
2012 | 52 | 4 | 56 |
2013 | 58 | 5 | 63 |
2014 | 51 | 6 | 57 |
2015 | 74 | 9 | 83 |
2016 | 71 | 11 | 82 |
2017 | 61 | 3 | 64 |
2018 | 73 | 6 | 79 |
2019 | 74 | 7 | 81 |
2020 | 74 | 6 | 80 |
2021 | 89 | 3 | 92 |
2022 | 68 | 0 | 68 |
2023 | 71 | 0 | 71 |
2024 | 63 | 6 | 69 |
2025 | 9 | 0 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non-Small Cell Lung Cancer in Patients. Cancer Discov. 2025 Apr 02; 15(4):702-716.
-
The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancer. Cell Rep Med. 2025 Mar 18; 6(3):101983.
-
Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer. Eur J Cancer. 2025 May 02; 220:115323.
-
Proceedings of the 1st biannual bridging the gaps in lung cancer conference. Oncologist. 2025 Feb 06; 30(2).
-
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1=50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry. J Immunother Cancer. 2025 Feb 04; 13(2).
-
Preoperative Chest CT Myosteatosis Indicates Worse Postoperative Survival in Stage 0-IIB Non-Small Cell Lung Cancer. Radiology. 2025 Feb; 314(2):e240282.
-
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening. Eur J Cancer. 2025 Mar 11; 218:115264.
-
The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer. Ann Thorac Surg. 2025 Mar; 119(3):495-508.
-
Targeting CNS Metastases in Non-Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers: A Review. JAMA Oncol. 2025 Jan 01; 11(1):60-69.
-
NCCN GuidelinesĀ® Insights: Lung Cancer Screening, Version 1.2025. J Natl Compr Canc Netw. 2025 01; 23(1).